Vasodilator testing with nitric oxide and/or oxygen in pediatric pulmonary hypertension (Q42657405)

4 November 2017

Vasodilator testing with nitric oxide and/or oxygen in pediatric pulmonary hypertension (English)

1 reference

4 November 2017

Robyn J Barst

1

1 reference

4 November 2017

Gabriella Agnoletti

2

1 reference

4 November 2017

Alain Fraisse

3

1 reference

4 November 2017

James Baldassarre

4

1 reference

4 November 2017

David L Wessel

5

1 reference

4 November 2017

NO Diagnostic Study Group

6

1 reference

4 November 2017

20 April 2010

1 reference

4 November 2017

1 reference

4 November 2017

31

1 reference

4 November 2017

5

1 reference

4 November 2017

598-606

1 reference

https://scigraph.springernature.com/pub.10.1007/s00246-010-9645-5

4 November 2017

0 references

cites work

Vasodilator therapy for primary pulmonary hypertension in children

1 reference

https://api.crossref.org/works/10.1007%2FS00246-010-9645-5

Effect of breathing oxygen on pulmonary artery pressure and pulmonary vascular resistance in patients with ventricular septal defect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-010-9645-5

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-010-9645-5

Inhaled nitric oxide in congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-010-9645-5

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00246-010-9645-5

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

21 January 2018

1 reference

12 December 2020

Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology.

1 reference

12 December 2020

Outcomes in children with idiopathic pulmonary arterial hypertension.

1 reference

12 December 2020

Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators

1 reference

12 December 2020

Incidents and complications during pediatric cardiac catheterization.

1 reference

12 December 2020

Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension.

1 reference

12 December 2020

Diagnosis and assessment of pulmonary arterial hypertension.

1 reference

12 December 2020

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

1 reference

12 December 2020

Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

1 reference

12 December 2020

Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension

1 reference

12 December 2020

Inhaled Nitric Oxide as a Preoperative Test (INOP Test I): the INOP Test Study Group.

1 reference

12 December 2020

Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension

1 reference

12 December 2020

A comparison of inhaled nitric oxide with intravenous vasodilators in the assessment of pulmonary haemodynamics prior to cardiac transplantation

1 reference

12 December 2020

Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing.

1 reference

12 December 2020

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

1 reference

12 December 2020

Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension

1 reference

12 December 2020

Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension

1 reference

12 December 2020

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

1 reference

12 December 2020

Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.

1 reference

12 December 2020

10.1007/S00246-010-9645-5

Identifiers

DOI

1 reference

Dimensions Publication ID

4 November 2017

0 references

1 reference